Figure 4.
Effect of DrotAA infusion on protein C levels in PROWESS [9]. Shown are percentage changes in protein C level from baseline until day 7; the data are the observed data with no imputation. DrotAA, drotrecogin alfa (activated); PROWESS, Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis.
Vangerow et al. Critical Care 2007 11(Suppl 5):S4 doi:10.1186/cc6155